Capital Group Is Said to Eye Stake in China Biotech Unicorn

(Bloomberg) -- Capital Group Cos., the U.S. asset manager that’s been backing startups in emerging markets, is in talks to invest in Chinese biopharmaceutical firm Innovent Biologics Inc., people w...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.